Pericardial bleeding risk with non-vitamin K oral anticoagulants: a meta-analysis

Affiliations

¹ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal; Cardiology Department, Hospital Garcia de Orta, Almada, Portugal. Electronic address: dgcaldeira@hotmail.com.
² Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
³ Cardiology Department, CCUL, CAML, Faculty of Medicine, Lisbon, Portugal.
⁴ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal.
⁵ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal; Portuguese Collaborating Centre of the Cochrane Iberoamerican Network, Faculty of Medicine, University of Lisbon, Portugal; Evidence Based Medicine Centre, Faculty of Medicine, University of Lisbon, Portugal.

Comment

Daniel Caldeira et al. Int J Cardiol. 2015.

. 2015 Mar 1:182:187-8.

doi: 10.1016/j.ijcard.2014.12.062. Epub 2014 Dec 23.

¹ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal; Cardiology Department, Hospital Garcia de Orta, Almada, Portugal. Electronic address: dgcaldeira@hotmail.com.
² Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
³ Cardiology Department, CCUL, CAML, Faculty of Medicine, Lisbon, Portugal.
⁴ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal.
⁵ Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal; Portuguese Collaborating Centre of the Cochrane Iberoamerican Network, Faculty of Medicine, University of Lisbon, Portugal; Evidence Based Medicine Centre, Faculty of Medicine, University of Lisbon, Portugal.

No abstract available

Keywords: Apixaban; Dabigatran; Edoxaban; Meta-analysis; Pericardial bleeding; Pericarditis; Rivaroxaban.

Comment on

Life-threatening haemorrhagic pericarditis associated with rivaroxaban.
Xu B, MacIsaac A. Xu B, et al. Int J Cardiol. 2014 Jun 15;174(2):e75-6. doi: 10.1016/j.ijcard.2014.04.151. Epub 2014 Apr 21. Int J Cardiol. 2014. PMID: 24794963 No abstract available.